Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease
NCT01739517Phase 2Unknown
- Start
- Mar 2009
- Primary completion
- Dec 2013
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in Parenteral Nutrition Associated Liver Disease (PNALD), cholestasis. Status: unknown.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
Parenteral Nutrition Associated Liver Disease (PNALD)cholestasis
Beyond the preview
Go deeper on NCT01739517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01739517.